Search research articles
Contact Us
Filters
Showing results (11-20 of 81) with videos related to
Page
of 9
Sort By:
DICP : the Annals of Pharmacotherapy
|
September 1, 1991
Trimethoprim/sulfamethoxazole concentrations in pneumocystis carinii Pneumonia
S M Erdman, K A Rodvold
Clinical Pharmacokinetics
|
June 8, 2000
Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics
D T Bearden, K A Rodvold
Lancet (London, England)
|
April 18, 2000
Antibiotic policies in neonatal intensive-care units
J P Quinn, K A Rodvold
Clinical Pharmacy
|
June 1, 1987
Recognition and importance of Staphylococcus epidermidis infections
R A Blum, K A Rodvold
Clinical Pharmacy
|
August 1, 1988
Aminoglycoside pharmacokinetic monitoring: an integral part of patient care?
K A Rodvold, H Zokufa, J C Rotschafer
Clinical Pharmacy
|
May 1, 1986
Accuracy of 11 methods for predicting theophylline dose
K A Rodvold, F P Paloucek, M Zell
Clinical Pharmacy
|
August 1, 1987
Routine monitoring of serum vancomycin concentrations: can waiting be justified?
K A Rodvold, H Zokufa, J C Rotschafer
Clinical Pharmacokinetics
|
June 1, 1992
Phenobarbital pharmacokinetics in obesity. A case report
L Wilkes, L H Danziger, K A Rodvold
Journal of Toxicology. Clinical Toxicology
|
January 1, 1994
Prediction of acetaminophen concentrations in overdose patients using a Bayesian pharmacokinetic model
C A Gentry, F P Paloucek, K A Rodvold
Clinical Pharmacokinetics
|
June 1, 1991
An updated comparison of drug dosing methods. Part IV: Vancomycin
R D Pryka, K A Rodvold, S M Erdman
Page
of 9
Search research articles
Search
Showing results (11-20 of 81) with videos related to
Sort By:
Page
of 9
DICP : the Annals of Pharmacotherapy
|
September 1, 1991
Trimethoprim/sulfamethoxazole concentrations in pneumocystis carinii Pneumonia
S M Erdman, K A Rodvold
Clinical Pharmacokinetics
|
June 8, 2000
Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics
D T Bearden, K A Rodvold
Lancet (London, England)
|
April 18, 2000
Antibiotic policies in neonatal intensive-care units
J P Quinn, K A Rodvold
Clinical Pharmacy
|
June 1, 1987
Recognition and importance of Staphylococcus epidermidis infections
R A Blum, K A Rodvold
Clinical Pharmacy
|
August 1, 1988
Aminoglycoside pharmacokinetic monitoring: an integral part of patient care?
K A Rodvold, H Zokufa, J C Rotschafer
Clinical Pharmacy
|
May 1, 1986
Accuracy of 11 methods for predicting theophylline dose
K A Rodvold, F P Paloucek, M Zell
Clinical Pharmacy
|
August 1, 1987
Routine monitoring of serum vancomycin concentrations: can waiting be justified?
K A Rodvold, H Zokufa, J C Rotschafer
Clinical Pharmacokinetics
|
June 1, 1992
Phenobarbital pharmacokinetics in obesity. A case report
L Wilkes, L H Danziger, K A Rodvold
Journal of Toxicology. Clinical Toxicology
|
January 1, 1994
Prediction of acetaminophen concentrations in overdose patients using a Bayesian pharmacokinetic model
C A Gentry, F P Paloucek, K A Rodvold
Clinical Pharmacokinetics
|
June 1, 1991
An updated comparison of drug dosing methods. Part IV: Vancomycin
R D Pryka, K A Rodvold, S M Erdman
Page
of 9